Lung cancer patients now have another treatment option. For those tumors carrying HER2 mutations, can now be treated with trastuzumab deruxtecan. This drug is already approved for use in HER2-positive breast cancer…
Category: Lung Cancer News
Study Finds New Links between Genes and Lung Cancer
Lung Cancer is one of the most common cancers and according to the American Cancer Society; it is by far the leading cause of cancer deaths. August 1 is observed as World…
High Lung Cancer Risk among Smokers for Whom Screening is not Recommended
According to the research paper published in the Journal of the American Medical Association (JAMA) Oncology, some current and former older smokers who are not recommended for screening are at high risk…
Study finds Biomarker in Liquid Biopsy for Lung Cancer Appears Accurate in Predicting Immunotherapy Response
The researchers at Mount Sinai have found that a simple blood test called liquid biopsy could be a better indicator of whether cancer immunotherapy will be successful for lung cancer patients than…
Imaging Approach to Detect Lung Cancer Earlier, Study Reveals
Lung cancer is the third most common type of cancers in the United States, according to the Cancers for Disease Control and Prevention. A new study has found a new way for…
Moffitt Researchers Find New Target for CAR T Cells in Solid Tumors
The researchers from Moffitt Cancer Center in Tampa, Florida have published results identifying the potential target for Chimeric Antigen Receptor (CAR) T-cell therapies in solid tumors. The findings have been published in…
Emphysema on Computed Tomography – Associated with Increased Risk of Lung Cancer
Lung cancer is responsible for cancer-related deaths worldwide. Continuous research and studies are being carried out to reduce its risk. According to a new study published in Radiology, Computed Tomography detected emphysema is…
Study Suggests Why Some Tobacco Smokers Don’t Get Lung Cancer
One of the major causes behind lung cancer remains smoking, yet only a minority of smokers develops this disease. A new study has been led by scientists at Albert Einstein College of…
FDA Approves Nivolumab Plus Chemo as Neoadjuvant Therapy for NSCLC Treatment
The FDA has approved nivolumab plus platinum-doublet chemotherapy for patients with non-small cell lung cancer in the neoadjuvant setting. Nivolumab is the first immune checkpoint inhibitor to get approval for resectable NSCLC….
New Rapid Blood Test To Detect Early Stage Lung Cancer
In the arena of lung cancer, new researches and studies are being carried out all around the world to help the patients in its early detection and timely cure. One of the…
Lung Cancer Screening in Non-Smoker Women in Taiwan Associated with Overdiagnosis
A new study based on data from a National Cancer Registry in Taiwan has found that lung cancer screening may lead to overdiagnosis at the population level. The United States Preventive Services…
NICE Approves Combination Therapy for Squamous Non-Small Cell Lung Cancer
There are mainly two different groups of lung cancer: non-small cell lung cancer and small cell lung cancer. These groups can further be split into more groups depending on where and how…